Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2008
Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment
G Cartron, M Ohresser, G Salles, et al.
Leukemia & Lymphoma
|
August 10, 1999
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome
M Delain, G Cartron, M Bout, et al.
The Journal of Infection
|
July 10, 2003
Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure
J Dereure, H Duong Thanh, T Lavabre-Bertrand, et al.
Current Research in Translational Medicine
|
March 12, 2018
Infusion of in vivo expanded cord blood lymphocytes: A new strategy to control residual disease?
S Lamure, J Delage, L Vincent, et al.
Transplantation Proceedings
|
August 30, 2016
Treatment Response and Outcomes in Post-transplantation Lymphoproliferative Disease vs Lymphoma in Immunocompetent Patients
R Trusson, J E Serre, I Szwarc, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
December 3, 2014
[Kinetic and organization of granulocytes transfusion: a case report]
S Lamure, P Latry, T Kanouni, et al.
International Journal of Hematology
|
March 12, 2003
Proliferation of human progenitor cells in a long-term culture system is more efficiently sustained by the addition of Flt-3 ligand or megakaryocyte growth and development factor than by Kit ligand
G Cartron, C Binet, O Hérault, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels
L Benboubker, C Valat, C Linassier, et al.
Leukemia & Lymphoma
|
June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma
G Cartron, L Voillat, B Desablens, et al.
Annals of Hematology
|
March 12, 2022
Discontinuation of tyrosine kinase inhibitor in chronic myeloid leukemia: a retrospective cohort in east occitania
J B Robin, A Theron, P Quittet, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2008
Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment
G Cartron, M Ohresser, G Salles, et al.
Leukemia & Lymphoma
|
August 10, 1999
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome
M Delain, G Cartron, M Bout, et al.
The Journal of Infection
|
July 10, 2003
Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure
J Dereure, H Duong Thanh, T Lavabre-Bertrand, et al.
Current Research in Translational Medicine
|
March 12, 2018
Infusion of in vivo expanded cord blood lymphocytes: A new strategy to control residual disease?
S Lamure, J Delage, L Vincent, et al.
Transplantation Proceedings
|
August 30, 2016
Treatment Response and Outcomes in Post-transplantation Lymphoproliferative Disease vs Lymphoma in Immunocompetent Patients
R Trusson, J E Serre, I Szwarc, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
December 3, 2014
[Kinetic and organization of granulocytes transfusion: a case report]
S Lamure, P Latry, T Kanouni, et al.
International Journal of Hematology
|
March 12, 2003
Proliferation of human progenitor cells in a long-term culture system is more efficiently sustained by the addition of Flt-3 ligand or megakaryocyte growth and development factor than by Kit ligand
G Cartron, C Binet, O Hérault, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels
L Benboubker, C Valat, C Linassier, et al.
Leukemia & Lymphoma
|
June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma
G Cartron, L Voillat, B Desablens, et al.
Annals of Hematology
|
March 12, 2022
Discontinuation of tyrosine kinase inhibitor in chronic myeloid leukemia: a retrospective cohort in east occitania
J B Robin, A Theron, P Quittet, et al.
Page
of 4